Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Additional Reading from MarketBeat.com 3 Blue-Chip Stocks Built for a Rotating MarketAuthored by Chris Markoch. Posted: 3/8/2026. 
Summary - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
Sector rotation occurs when investors shift capital out of sectors that look overbought and into those that seem undervalued. In 2026, that has meant moving away from mega-cap technology and toward value stocks, especially defensive sectors such as energy and consumer staples. The key issue is overvaluation. Big tech has run hot for more than two years, driven primarily by the emergence of artificial intelligence (AI). Despite concerns about a dot‑com–style bubble, investors largely ignored the lofty valuations of many of these names. Investors who thought "this time is different" are discovering that valuation matters eventually. As the economy heats up, money is flowing into value elsewhere, including blue-chip defensive names such as the stocks below. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Utilities are among the most defensive sectors, typically considered value and income plays. Duke Energy offers an attractive, relatively secure dividend yielding around 3.2% and has raised its payout for 20 consecutive years. The evolving U.S. energy landscape also presents growth opportunities for DUK. Duke follows an "all-of-the-above" power strategy, including nuclear, hydroelectric and natural gas. Natural gas has helped fuel the stock's strong bounce in 2026, but investors are also drawn to Duke's stable residential utility revenue and growth prospects in areas such as data centers — making DUK a target for sector-rotation flows. DUK is up nearly 12% so far in 2026, putting it within about 5% of the consensus price target of $136.87 — a level that would push it above its 52-week high. At roughly 20.5x earnings, the stock trades at a slight premium to its historical average. Since Duke's February earnings report, analysts have raised price targets amid expectations for stronger year-over-year revenue growth in the second half of the year, which could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts expect biotechnology and other healthcare stocks to benefit from sector rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within a healthcare sector that has largely underperformed the broader market. Gilead is a leading provider of HIV therapies, many of which retain patent protection into the 2030s. Investors are encouraged by a pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026, and may secure a label expansion for its breast-cancer treatment, Trodelvy. GILD is up nearly 18% in 2026 and reached a 52-week high, though it has pulled back slightly amid some profit-taking. That dip could present a buy-the-dip opportunity. Analysts' consensus price target sits at $156.72, implying upside of roughly 8%. Since the February earnings report, several analysts have raised targets, with the highest at about $170. Gilead pays a reliable dividend yielding about 2.28% and has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been one of the biggest beneficiaries of the rotation into consumer staples in 2026. HSY is up nearly 25% this year and has broken out of a bearish trend that began in 2023. Hershey struggled beginning in 2023 with elevated cocoa costs that extended through 2025, and those headwinds may still pressure 2026 earnings. Still, the market looks forward, and analysts expect solid earnings and revenue growth in 2026. HSY has traded above the consensus price target of $222.21, but since the February earnings report analysts have been increasing targets — with Goldman Sachs the most bullish at $267. In the earnings report, Hershey raised its dividend by 5.9%, marking 15 consecutive years of increases. The stock yields roughly 2.5%, with an annual payout of $5.81 per share. Following the recent rally, HSY trades at over 50x earnings — a valuation that likely triggered heavy institutional selling in the last quarter, but which could also give investors a chance to buy on weakness.
| 
